Two Indian generic drugmakers – Hetero and Dr Reddy’s – will be funded by the Gates Foundation and Unitaid, respectively, to ...
43mon MSNOpinion
I'm An Infectious Disease Doctor. Here's What Happened When I Sat Next To A Vaccine Skeptic On A Plane.
"As someone who recently completed 15 years of training to become an infectious diseases physician-scientist, I can’t avoid ...
Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug ...
Africa is at the center of the global problem of neglected tropical diseases (NTDs). The continent carries about - 40 % of the worldwide NTD burden, impacting over 500 million people. Twenty of the 21 ...
Now, new book is putting forward a strategy built around a simple formula that aims to reexamine our approach to both public ...
Everyday Health on MSN
Managing MASH With Supplements: What’s Safe and What’s Risky
Learn which dietary supplements may be beneficial for the treatment of MASH, as well as which ones should be avoided due to potential liver injury risks.
Uganda is set to become one of the first ten countries in the world to receive lenacapavir, a groundbreaking HIV prevention drug introduced by the United States government through the President's ...
Gilead has agreed to provide the drug at cost and to share its intellectual property with generic manufacturers who can ...
The Italian Institute for Nuclear Physics conducts cutting-edge research in the field of nuclear, particle, and astroparticle ...
News-Medical.Net on MSN
Inflammation at the heart’s core: What clinicians and families can do now
Chronic low-grade inflammation is a key driver of cardiovascular disease, even when cholesterol is controlled. The ACC’s 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results